This inventor holds 9 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1976-2002.
Company Filing History:
Years Active: 1976-2002
Title: Innovations and Contributions of Stephen S. Massett
Introduction
Stephen S. Massett is a notable inventor based in Groton, Connecticut, with a significant portfolio of nine patents. His work primarily focuses on pharmaceutical compositions and innovative methods that enhance drug stability and efficacy. Massett's contributions have made a substantial impact in the field of medicine, particularly in treatments for patients undergoing chemotherapy.
Latest Patents
Among his latest patents, Massett has developed polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate. These include two crystalline polymorphic forms known as Form A and Form B. The pharmaceutical composition containing these polymorphs demonstrates advantageous stability for formulations aimed at treating acute emesis in chemotherapy patients. The administration methods for this composition are conventional oral, preferably in tablet or capsule form, as well as intravenous. Additionally, he has patented a process for converting 1,1-bis(p-fluorophenyl)urea into 2-carbobenzoxy-8-fluoro-5-(p-fluorophenyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole, which further leads to the synthesis of flutroline and its intermediates.
Career Highlights
Stephen S. Massett has built a distinguished career at Pfizer Corporation, where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have contributed to the creation of effective treatments that address critical health issues.
Collaborations
Massett has collaborated with esteemed colleagues, including Berkeley W. Cue and Philip D. Hammen, to further enhance the scope and impact of his inventions. Their combined expertise has fostered a collaborative environment that drives innovation in pharmaceutical sciences.
Conclusion
Stephen S. Massett's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving patient care through advanced drug formulations and methods. His contributions continue to influence the field and pave the way for future advancements.